
AML.L vs PSNY

In the past 12 months, AML.L returned -42% while PSNY lost 86%.
Valuation
Compare price multiples and valuation ratios
| Metric | AML.L | PSNY | Winner |
|---|---|---|---|
P/E Ratio Price to earnings ratio | -0.60 | -0.22 | AML.L |
Forward P/E Forward price to earnings ratio | 0.00 | 0.00 | Tie |
P/S Ratio Price to sales ratio | 0.22 | 0.22 | PSNY |
P/B Ratio Price to book ratio | 2.11 | -0.11 | PSNY |
P/FCF Ratio Price to free cash flow ratio | -1.49 | -0.29 | AML.L |
EV/EBITDA Enterprise value to EBITDA | 7.44 | -5.71 | PSNY |
PEG Ratio Price/earnings to growth ratio | 0.00 | 0.00 | Tie |
Profitability
Compare profit margins and returns on capital
| Metric | AML.L | PSNY | Winner |
|---|---|---|---|
Gross Margin Gross profit margin | 18.5% | -4.5% | AML.L |
Operating Margin Operating profit margin | -13.3% | -52.3% | AML.L |
Net Margin Net profit margin | -36.7% | -66.8% | AML.L |
ROE Return on equity | -166.6% | 40.0% | PSNY |
ROA Return on assets | -23.7% | -56.0% | AML.L |
ROIC Return on invested capital | -11.5% | -98.9% | AML.L |
Growth
Compare revenue and earnings growth rates
| Metric | AML.L | PSNY | Winner |
|---|---|---|---|
Revenue Growth (YoY) Year-over-year revenue growth | -20.6% | 50.3% | PSNY |
Revenue Growth (3Y) 3-year revenue CAGR | -3.1% | 7.8% | PSNY |
Revenue Growth (5Y) 5-year revenue CAGR | 15.5% | 38.0% | PSNY |
EPS Growth (YoY) Year-over-year EPS growth | -28.2% | 12.4% | PSNY |
EPS Growth (3Y) 3-year EPS CAGR | 0.0% | 0.0% | Tie |
EPS Growth (5Y) 5-year EPS CAGR | 0.0% | 0.0% | Tie |
Balance Sheet & Risk
Compare financial stability and debt levels
| Metric | AML.L | PSNY | Winner |
|---|---|---|---|
Debt/Equity Debt to equity ratio | 8.94 | -1.27 | PSNY |
Current Ratio Current assets to current liabilities | 0.93 | 0.32 | AML.L |
Quick Ratio Quick assets to current liabilities | 0.49 | 0.22 | AML.L |
Interest Coverage EBIT to interest expense | -1.43 | -8.33 | AML.L |
Beta Stock volatility vs market | 1.94 | 1.73 | PSNY |
7222.T
LOT